See also this year's filing and all EDGAR filings for this company.
PDF Report 0001168220_2018_Altrazeal_Life_Sciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('EntityCommonStockSharesOutstanding')"} |
Graph
Absolute values for 0001168220, Altrazeal Life Sciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 4,635,152 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 179,737 |
| 2 | PropertyPlantAndEquipmentNet | 53,723 |
| 3 | remainder_Assets | 3,674,705 |
| 4 | LiabilitiesCurrent | 1,512,634 |
| 5 | LiabilitiesNoncurrent | 922,887 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,478,018 |
| 9 | ResearchAndDevelopmentExpense | 239,948 |
| 10 | remainder_Expenses | 1,158,372 |
| 11 | remainder_Revenues | 717,157 |
| 12 | remainder_NetIncome | 222,893 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,543,317 |
| 1 | Liabilities | 2,435,521 |
| 2 | Expenses | 2,876,338 |
| 3 | Revenues | 717,157 |
| 4 | StockholdersEquity | 6,107,796 |
| 5 | NetIncome | -1,936,288 |
| 6 | ComprehensiveNetIncome | -1,936,288 |
| 7 | BaseVar | 7,397,613 |
| 8 | EconomicCapitalRatio | 1.56 |